2023European Urology Open ScienceOpen access

The probability of metastases within different Prostate-Specific Antigen (PSA) ranges using Prostate-Specific Membrane Antigen (PSMA) positron emission tomography in patients with newly diagnosed prostate cancer

W.I. Luining, M.J. Hagens, Dennie Meijer, R.H. Ettema, R. Jeroen A. van Moorselaar, Peter Jan van Leeuwen, Daniela E. Oprea‐Lager, André N. Vis

Open full text 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Prostate cancer, Glutamate carboxypeptidase II, Positron emission tomography, Medicine, Prostate-specific antigen, Antigen, Oncology, Prostate

Related papers

Back to paper searchBrowse research topicsOriginal source
The probability of metastases within different Prostate-Specific Antigen (PSA) ranges using Prostate-Specific Membrane Antigen (PSMA) positron emission tomography in patients with newly diagnosed prostate cancer — Research Paper | ScholarLens